MAM
Tejinder Gill moves on from Truecaller, joins The Trade Desk
MUMBAI: Tejinder Gill has moved on from Truecaller where he was the vice-president of global sales (South Asia, MENA, and Sub Saharan Africa). Gill has now joined US based tech firm The Trade Desk as the general manager for India.
He had announced his departure from Truecaller at the end of last year, after a nearly five years’ association with the company.
In his new role, Gill will be responsible for crafting innovative approaches to accelerate outcomes based on emerging business models and strengthening global client and partner relationships.
“I’m happy to share that I have started the next leg of my career journey with The Trade Desk. My focus here will be to drive our vision of reshaping digital advertising in the India geo. I’m excited to work with a great team that will use its expertise to transform media to benefit businesses and build advanced opportunities in the Open Internet for India’s modern marketers to navigate this next era of change,” Gill announced the move on LinkedIn on Tuesday.
Gill joined Truecaller in 2016 and spent four and a half years at the caller identification app before his move to The Trade Desk. In a career spanning over 17 years, he has worked at places like LinkedIn, Yahoo, Times of India, Network18, and SAS International Export.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
